CONVATEC GROUP

CONVATEC GROUP Share · GB00BD3VFW73 · A2AUD3 (XLON) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of CONVATEC GROUP
No Price
Closing Price XLON 01.05.2026: 210,80 GBX
01.05.2026 15:12
Current Prices from CONVATEC GROUP
ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
CTEC.L
GBX
01.05.2026 15:12
210,80 GBX
0,00 GBX
OTC: UTC
UTC
CNVVF
USD
30.04.2026 20:00
2,99 USD
-0,23 USD
-7,14 %
XDUS: Düsseldorf
Düsseldorf
CTGPLC73.DUSB
EUR
30.04.2026 17:31
2,44 EUR
-0,30 EUR
-10,95 %
XHAN: Hannover
Hannover
CTGPLC73.HANB
EUR
30.04.2026 15:25
2,46 EUR
-0,28 EUR
-10,22 %
XDQU: Quotrix
Quotrix
CTGPLC73.DUSD
EUR
30.04.2026 05:27
2,44 EUR
-
Share Float & Liquidity
Free Float 77,73 %
Shares Float 1,52 B
Shares Outstanding 1,95 B
Invested Funds

The following funds have invested in CONVATEC GROUP:

Fund
iShares MSCI UK Small Cap UCITS ETF GBP (Acc)
Vol. in million
5.062,27
Percentage (%)
0,87 %
Fund
iShares FTSE 250 UCITS ETF GBP (Dist)
Vol. in million
12.711,71
Percentage (%)
0,82 %
Fund
iShares STOXX Europe Small 200 UCITS ETF (DE)
Vol. in million
3.647,36
Percentage (%)
0,57 %
Fund
iShares MSCI UK IMI ESG Leaders UCITS ETF GBP (Dist)
Vol. in million
22,17
Percentage (%)
0,41 %
Company Profile for CONVATEC GROUP Share
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

Company Data

Name CONVATEC GROUP
Company ConvaTec Group Plc
Website https://www.convatecgroup.com
Primary Exchange XLON London
WKN A2AUD3
ISIN GB00BD3VFW73
Asset Class Share
Sector Healthcare
Industry Medical - Instruments & Supplies
CEO John Haller
Market Capitalization 4 Mrd.
Country United Kingdom
Currency GBP
Employees 10,5 T
Address 3 Forbury Place, RG1 3JH Reading
IPO Date 2016-10-26
Dividends from 'CONVATEC GROUP'
Ex-Date Dividend per Share
16.04.2026 3,97 GBX
21.08.2025 1,40 GBX
17.04.2025 3,64 GBX
22.08.2024 1,42 GBX
25.04.2024 3,52 GBX
17.08.2023 1,38 GBX
06.04.2023 0,04 USD
25.08.2022 1,41 GBX
24.08.2022 0,02 USD
31.03.2022 3,16 GBX

Stock Splits

Date Split
17.08.2023 161.14:160.14
10.04.2023 61.49:60.49
25.08.2022 155.5:154.5
31.03.2022 69.09:68.09
02.09.2021 184.95:183.95
05.04.2021 70.24:69.24
03.09.2020 143.63:142.63
02.04.2020 59.07:58.07
05.09.2019 125.26:124.26
04.04.2019 45.32:44.32
06.09.2018 175.28:174.28
05.04.2018 66.36:65.36

Ticker Symbols

Name Symbol
Over The Counter CNVVF
Düsseldorf CTGPLC73.DUSB
Frankfurt 2CV.F
Hannover CTGPLC73.HANB
London CTEC.L
Quotrix CTGPLC73.DUSD
More Shares
Investors who hold CONVATEC GROUP also have the following shares in their portfolio:
AB S.I-INT.H.CARE PTF.IEO
AB S.I-INT.H.CARE PTF.IEO Fund
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
BIOGEN INC
BIOGEN INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
EBAY INC
EBAY INC Share
F.TEM.INV-MUT.EU.N ACC.EO
F.TEM.INV-MUT.EU.N ACC.EO Fund
GCM GROSVENOR INC - CLASS A
GCM GROSVENOR INC - CLASS A Share
HYSAN (MTN) 19/29 MTN
HYSAN (MTN) 19/29 MTN Bond
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
O'REILLY AUTOMOTIVE INC
O'REILLY AUTOMOTIVE INC Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share